Filgrastim is a medication used to manage and treat neutropenia in patients with myelosuppression from chemotherapy or radiation, which increases the risk of infection and related events. This activity outlines the indications, actions, contraindication, adverse effects, and other important details of filgrastim as it pertains to members of the interprofessional team in clinical practice in the management of neutropenia and its clinical sequelae.

**Objectives:**
- Identify the mechanism of action of filgrastim. 
- Describe the potential adverse effects of filgrastim.
- Review the appropriate monitoring for patients who receive filgrastim.
- Outline interprofessional team strategies for improving care coordination and communication to advance filgrastim and improve outcomes.